全球肺功能检测系统市场规模、份额、趋势和成长分析报告（2026-2034年）

肺功能测试系统市场预计将从 2025 年的 36.3 亿美元成长到 2034 年的 67.1 亿美元，预计从 2026 年到 2034 年将以 7.07% 的复合年增长率成长。

全球肺功能检测系统市场稳定成长，主要受气喘、慢性阻塞性肺病（COPD）和肺部感染疾病等呼吸道疾病日益普遍的推动。医疗专业人员越来越依赖肺功能检测来评估肺活量、气流和整体呼吸健康状况。诊断设备的科技进步和数位化监控工具的整合提高了这些系统的准确性和效率。人们对疾病早期检测意识的提高以及对医疗基础设施投入的增加也促进了市场扩张。

推动此市场成长的关键因素包括：吸烟相关肺部疾病发生率的上升以及老年人口的成长，这些因素共同推动了呼吸系统诊断的需求。医院和诊断检查室正在采用具备自动化数据分析和携带式检测功能的先进检测系统。此外，日益严重的空气污染以及职业性有害颗粒物暴露，也增加了定期进行呼吸系统健康评估的必要性，从而进一步促进了肺功能检测设备的普及。

在创新和医疗服务覆盖范围不断扩大的推动下，市场预计将持续成长。随着远端患者监护的普及，携带式和家用肺功能检测设备有望得到更广泛的应用。与数位健康平台和人工智慧的整合有望提高诊断准确性和患者管理水平。在新兴经济体，随着医疗体系的现代化以及各国政府加大对呼吸系统疾病筛检和预防医学的投入，预计将涌现庞大的商机。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球肺功能测试系统市场：依产品划分

• 市场分析、洞察与预测
• 携带式的
• 桌面型

第五章 全球肺功能检测系统市场：依检测类型划分

• 市场分析、洞察与预测
• 肺功能测定
• 运动压力测试
• 肺容量测试
• 高空模拟试验
• 气体扩散法
• 其他测试类型

第六章 全球肺功能测试系统市场：依应用划分

• 市场分析、洞察与预测
• 慢性阻塞性肺病
• 气喘
• 慢性呼吸困难
• 肺纤维化
• 其他用途

第七章 全球肺功能测试系统市场：依最终用途划分

• 市场分析、洞察与预测
• 医院和诊所
• 诊断中心
• 居家医疗环境
• 其他最终用户

第八章 全球肺功能检测系统市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Baxter International Inc
  • Chest MI Inc
  • COSMED Srl
  • ECO Medics AG
  • Fukuda Sangyo Co. Ltd
  • Ganshorn Medizin Electronic GmbH（Schiller Group）
  • Geratherm Respiratory GmbH
  • Medical Equipment Europe GmbH
  • MGC Diagnostics Corporation
  • Minato Medical Science Co. Ltd
  • Morgan Scientific Inc

The Pulmonary Function Testing Systems Market size is expected to reach USD 6.71 Billion in 2034 from USD 3.63 Billion (2025) growing at a CAGR of 7.07% during 2026-2034.

The global pulmonary function testing systems market has grown steadily due to the rising prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease, and lung infections. Healthcare providers increasingly rely on pulmonary function tests to assess lung capacity, airflow, and overall respiratory health. Technological advancements in diagnostic equipment and the integration of digital monitoring tools have improved the accuracy and efficiency of these systems. Growing awareness about early disease detection and increasing healthcare infrastructure investments have also supported the market's expansion.

Several key drivers are fueling the growth of this market. The increasing incidence of smoking-related lung disorders and the growing geriatric population have created greater demand for respiratory diagnostics. Hospitals and diagnostic laboratories are adopting advanced testing systems that offer automated data analysis and portable testing capabilities. In addition, rising air pollution levels and occupational exposure to harmful particles have increased the need for routine respiratory health assessments, further encouraging the adoption of pulmonary function testing equipment.

Looking ahead, the market is expected to experience continued growth driven by innovation and expanding healthcare access. Portable and home-based pulmonary testing devices are likely to gain popularity as remote patient monitoring becomes more common. Integration with digital health platforms and artificial intelligence may enhance diagnostic accuracy and patient management. Emerging economies are expected to offer significant opportunities as healthcare systems modernize and governments invest more heavily in respiratory disease screening and preventive care.

MARKET SEGMENTATION

By Product

• Handheld
• Tabletop

By Test Type

• Spirometry
• Exercise Stress Test
• Lung Volume Test
• High Altitude Simulation Testing
• Gas Diffusion Test
• Other Test Types

By Application

• Chronic Obstructive Pulmonary Disease
• Asthma
• Chronic Shortness of Breath
• Pulmonary Fibrosis
• Other Applications

By End Use

• Hospitals & Clinics
• Diagnostic Centers
• Homecare Settings
• Other End Users

COMPANIES PROFILED

• Baxter International Inc, Chest MI Inc, COSMED Srl, ECO Medics AG, Fukuda Sangyo Co Ltd, Ganshorn Medizin Electronic GmbH Schiller Group, Geratherm Respiratory GmbH, Medical Equipment Europe GmbH, MGC Diagnostics Corporation, Minato Medical Science Co Ltd, Morgan Scientific Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Handheld Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Tabletop Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. Spirometry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Exercise Stress Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Lung Volume Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. High Altitude Simulation Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Gas Diffusion Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Other Test Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Chronic Obstructive Pulmonary Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Asthma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Chronic Shortness of Breath Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Pulmonary Fibrosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Homecare Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Test Type
  • 8.2.3 By Application
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Test Type
  • 8.3.3 By Application
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Test Type
  • 8.4.3 By Application
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Test Type
  • 8.5.3 By Application
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Test Type
  • 8.6.3 By Application
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PULMONARY FUNCTION TESTING SYSTEMS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Baxter International Inc
  • 10.2.2 Chest M.I. Inc
  • 10.2.3 COSMED Srl
  • 10.2.4 ECO Medics AG
  • 10.2.5 Fukuda Sangyo Co. Ltd
  • 10.2.6 Ganshorn Medizin Electronic GmbH (Schiller Group)
  • 10.2.7 Geratherm Respiratory GmbH
  • 10.2.8 Medical Equipment Europe GmbH
  • 10.2.9 MGC Diagnostics Corporation
  • 10.2.10 Minato Medical Science Co. Ltd
  • 10.2.11 Morgan Scientific Inc